BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30377101)

  • 21. Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma.
    Wu J; Chen P; Xie YG; Gong NM; Sun LL; Sun CF
    Pathol Oncol Res; 2015 Jul; 21(3):637-42. PubMed ID: 25466642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma.
    Nishikawa H; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T; Arimoto A; Osaki Y
    BMC Gastroenterol; 2011 Dec; 11():143. PubMed ID: 22204311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience.
    de la Serna S; Vilana R; Sánchez-Cabús S; Calatayud D; Ferrer J; Molina V; Fondevila C; Bruix J; Fuster J; García-Valdecasas JC
    HPB (Oxford); 2015 May; 17(5):387-93. PubMed ID: 25545319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study.
    Liang HH; Chen MS; Peng ZW; Zhang YJ; Zhang YQ; Li JQ; Lau WY
    Ann Surg Oncol; 2008 Dec; 15(12):3484-93. PubMed ID: 18679754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of effects of percutaneous radiofrequency ablation and surgical resection on small hepatocellular carcinoma].
    Chen MS; Li JQ; Liang HH; Lin XJ; Guo RP; Zheng Y; Zhang YQ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):80-3. PubMed ID: 15774210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of an ultrasound-guided radiofrequency ablation training program on the outcomes in patients with hepatocellular carcinoma.
    Takai Takamatsu R; Okano A; Yamakawa G; Mizukoshi K; Obayashi H; Ohana M
    Diagn Interv Imaging; 2019 Dec; 100(12):771-780. PubMed ID: 31477516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.
    Casaccia M; Andorno E; Nardi I; Troilo B; Barabino G; Santori G; Valente U
    J Laparoendosc Adv Surg Tech A; 2008 Dec; 18(6):797-801. PubMed ID: 18922065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application value of laparoscopic radiofrequency ablation for specific-location hepatocellular carcinoma].
    Shi HD; Shi XJ; Ma HX; Liang YR; Zhou L; Shi Y
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):56-59. PubMed ID: 28104035
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of three-dimensional reconstruction as a method of preoperative planning of laparoscopic radiofrequency ablation].
    Zhang WW; Wang HG; Shi XJ; Chen MY; Lu SC
    Zhonghua Wai Ke Za Zhi; 2016 Sep; 54(9):692-9. PubMed ID: 27587213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic ablation therapies for hepatocellular carcinoma: could specific indications for the laparoscopic approach influence the effectiveness?
    Santambrogio R; Barabino M; De Nicola E; Galfrascoli E; Giovenzana M; Zappa MA
    Updates Surg; 2020 Jun; 72(2):435-443. PubMed ID: 32246409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation.
    Yazici P; Akyuz M; Yigitbas H; Dural C; Okoh A; Aydin N; Berber E
    Surg Endosc; 2017 Mar; 31(3):1269-1274. PubMed ID: 27444839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.
    Lu MD; Xu HX; Xie XY; Yin XY; Chen JW; Kuang M; Xu ZF; Liu GJ; Zheng YL
    J Gastroenterol; 2005 Nov; 40(11):1054-60. PubMed ID: 16322950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Percutaneous radiofrequency ablation (PRFA) for hepatocellular carcinoma].
    Osaki Y; Kimura T; Kita R; Kokuryu H; Takamatsu S; Shimizu T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1640-5. PubMed ID: 11707998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy].
    Xu L; Li P; Chen MS; Pang XH; Gao HJ; Peng ZW; Liang HH; Zhang YJ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1617-20. PubMed ID: 19094753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
    Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
    Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.